Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles

We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (N1) activity indicate that...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2010-10, Vol.53 (20), p.7377-7391
Hauptverfasser: Mohan, Sankar, McAtamney, Sarah, Haselhorst, Thomas, von Itzstein, Mark, Pinto, Brian Mario
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7391
container_issue 20
container_start_page 7377
container_title Journal of medicinal chemistry
container_volume 53
creator Mohan, Sankar
McAtamney, Sarah
Haselhorst, Thomas
von Itzstein, Mark
Pinto, Brian Mario
description We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (N1) activity indicate that several candidates are inhibitors, with K i values in the 10−5−10−8 M range. In contrast, a known candidate that preserves the free amino group and a new candidate containing a guanidine function are better inhibitors, with K i values of 1.5 × 10−9 and 4.6 × 10−10 M, respectively. The most active inhibitor of the N1 enzyme in the triazole series was selective for the N1 class and showed significantly less inhibition (K i = 2.6 μM vs 0.07 μM) of the free influenza virus neuraminidase-2 (N2). In addition, saturation transfer difference (STD) NMR spectroscopic studies with this compound and the VLPs show that the entire molecule forms contacts with residues in the active site. These data taken together support our proposed binding mode in which the active site and the adjoining 150-cavity are both occupied.
doi_str_mv 10.1021/jm100822f
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_759874583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>759874583</sourcerecordid><originalsourceid>FETCH-LOGICAL-a314t-df0b8c43f6b578fd2cf9461f8b6a52c18dd4445c7fa0ecd8ab95fce09a2a51a13</originalsourceid><addsrcrecordid>eNpt0UFvFCEUwHFiNHZbPfgFDBfT9DAVGNhhjrqptUnTGlu9Tt7Aw7LOwApM4_a7-F2dzdaePHH55f-AR8gbzk45E_z9euSMaSHcM7LgSrBKaiafkwVjQlRiKeoDcpjzmjFWc1G_JAeC6aZuWrUgf1aQ-mi2ZsBMv-IABS0tkV5nHAqM_t4nCpleBDdMGB6AfvdpyvQ8xWlT8epmg8Y7b-gVTmnmwVvIOPM73_sSUz6lH32wPvzYRa84PQsP23Ee5QMtd0hXMRT8XWh0-3A1-J9Iv0AqfnejV-SFgyHj68fziHz7dHa7-lxdXp9frD5cVlBzWSrrWK-NrN2yV412VhjXyiV3ul-CEoZra6WUyjQOGBqroW-VM8haEKA48PqIHO-7mxR_TZhLN_pscBggYJxy16hWN1LpepYne2lSzDmh6zbJj5C2HWfdbhnd0zJm-_axOvUj2if57_dn8G4PwORuHacU5kf-J_QXWTSTXA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>759874583</pqid></control><display><type>article</type><title>Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles</title><source>MEDLINE</source><source>ACS Publications</source><creator>Mohan, Sankar ; McAtamney, Sarah ; Haselhorst, Thomas ; von Itzstein, Mark ; Pinto, Brian Mario</creator><creatorcontrib>Mohan, Sankar ; McAtamney, Sarah ; Haselhorst, Thomas ; von Itzstein, Mark ; Pinto, Brian Mario</creatorcontrib><description>We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (N1) activity indicate that several candidates are inhibitors, with K i values in the 10−5−10−8 M range. In contrast, a known candidate that preserves the free amino group and a new candidate containing a guanidine function are better inhibitors, with K i values of 1.5 × 10−9 and 4.6 × 10−10 M, respectively. The most active inhibitor of the N1 enzyme in the triazole series was selective for the N1 class and showed significantly less inhibition (K i = 2.6 μM vs 0.07 μM) of the free influenza virus neuraminidase-2 (N2). In addition, saturation transfer difference (STD) NMR spectroscopic studies with this compound and the VLPs show that the entire molecule forms contacts with residues in the active site. These data taken together support our proposed binding mode in which the active site and the adjoining 150-cavity are both occupied.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm100822f</identifier><identifier>PMID: 20873795</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Antiviral Agents - chemical synthesis ; Antiviral Agents - chemistry ; Catalytic Domain ; Influenza A virus - enzymology ; Magnetic Resonance Spectroscopy ; Models, Molecular ; Neuraminidase - antagonists &amp; inhibitors ; Neuraminidase - chemistry ; Oseltamivir - analogs &amp; derivatives ; Oseltamivir - chemical synthesis ; Oseltamivir - chemistry ; Protein Binding ; Stereoisomerism ; Triazoles - chemical synthesis ; Triazoles - chemistry ; Virion - drug effects ; Virion - enzymology</subject><ispartof>Journal of medicinal chemistry, 2010-10, Vol.53 (20), p.7377-7391</ispartof><rights>Copyright © 2010 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a314t-df0b8c43f6b578fd2cf9461f8b6a52c18dd4445c7fa0ecd8ab95fce09a2a51a13</citedby><cites>FETCH-LOGICAL-a314t-df0b8c43f6b578fd2cf9461f8b6a52c18dd4445c7fa0ecd8ab95fce09a2a51a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm100822f$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm100822f$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2764,27075,27923,27924,56737,56787</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20873795$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohan, Sankar</creatorcontrib><creatorcontrib>McAtamney, Sarah</creatorcontrib><creatorcontrib>Haselhorst, Thomas</creatorcontrib><creatorcontrib>von Itzstein, Mark</creatorcontrib><creatorcontrib>Pinto, Brian Mario</creatorcontrib><title>Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (N1) activity indicate that several candidates are inhibitors, with K i values in the 10−5−10−8 M range. In contrast, a known candidate that preserves the free amino group and a new candidate containing a guanidine function are better inhibitors, with K i values of 1.5 × 10−9 and 4.6 × 10−10 M, respectively. The most active inhibitor of the N1 enzyme in the triazole series was selective for the N1 class and showed significantly less inhibition (K i = 2.6 μM vs 0.07 μM) of the free influenza virus neuraminidase-2 (N2). In addition, saturation transfer difference (STD) NMR spectroscopic studies with this compound and the VLPs show that the entire molecule forms contacts with residues in the active site. These data taken together support our proposed binding mode in which the active site and the adjoining 150-cavity are both occupied.</description><subject>Antiviral Agents - chemical synthesis</subject><subject>Antiviral Agents - chemistry</subject><subject>Catalytic Domain</subject><subject>Influenza A virus - enzymology</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Models, Molecular</subject><subject>Neuraminidase - antagonists &amp; inhibitors</subject><subject>Neuraminidase - chemistry</subject><subject>Oseltamivir - analogs &amp; derivatives</subject><subject>Oseltamivir - chemical synthesis</subject><subject>Oseltamivir - chemistry</subject><subject>Protein Binding</subject><subject>Stereoisomerism</subject><subject>Triazoles - chemical synthesis</subject><subject>Triazoles - chemistry</subject><subject>Virion - drug effects</subject><subject>Virion - enzymology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0UFvFCEUwHFiNHZbPfgFDBfT9DAVGNhhjrqptUnTGlu9Tt7Aw7LOwApM4_a7-F2dzdaePHH55f-AR8gbzk45E_z9euSMaSHcM7LgSrBKaiafkwVjQlRiKeoDcpjzmjFWc1G_JAeC6aZuWrUgf1aQ-mi2ZsBMv-IABS0tkV5nHAqM_t4nCpleBDdMGB6AfvdpyvQ8xWlT8epmg8Y7b-gVTmnmwVvIOPM73_sSUz6lH32wPvzYRa84PQsP23Ee5QMtd0hXMRT8XWh0-3A1-J9Iv0AqfnejV-SFgyHj68fziHz7dHa7-lxdXp9frD5cVlBzWSrrWK-NrN2yV412VhjXyiV3ul-CEoZra6WUyjQOGBqroW-VM8haEKA48PqIHO-7mxR_TZhLN_pscBggYJxy16hWN1LpepYne2lSzDmh6zbJj5C2HWfdbhnd0zJm-_axOvUj2if57_dn8G4PwORuHacU5kf-J_QXWTSTXA</recordid><startdate>20101028</startdate><enddate>20101028</enddate><creator>Mohan, Sankar</creator><creator>McAtamney, Sarah</creator><creator>Haselhorst, Thomas</creator><creator>von Itzstein, Mark</creator><creator>Pinto, Brian Mario</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101028</creationdate><title>Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles</title><author>Mohan, Sankar ; McAtamney, Sarah ; Haselhorst, Thomas ; von Itzstein, Mark ; Pinto, Brian Mario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a314t-df0b8c43f6b578fd2cf9461f8b6a52c18dd4445c7fa0ecd8ab95fce09a2a51a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antiviral Agents - chemical synthesis</topic><topic>Antiviral Agents - chemistry</topic><topic>Catalytic Domain</topic><topic>Influenza A virus - enzymology</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Models, Molecular</topic><topic>Neuraminidase - antagonists &amp; inhibitors</topic><topic>Neuraminidase - chemistry</topic><topic>Oseltamivir - analogs &amp; derivatives</topic><topic>Oseltamivir - chemical synthesis</topic><topic>Oseltamivir - chemistry</topic><topic>Protein Binding</topic><topic>Stereoisomerism</topic><topic>Triazoles - chemical synthesis</topic><topic>Triazoles - chemistry</topic><topic>Virion - drug effects</topic><topic>Virion - enzymology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohan, Sankar</creatorcontrib><creatorcontrib>McAtamney, Sarah</creatorcontrib><creatorcontrib>Haselhorst, Thomas</creatorcontrib><creatorcontrib>von Itzstein, Mark</creatorcontrib><creatorcontrib>Pinto, Brian Mario</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohan, Sankar</au><au>McAtamney, Sarah</au><au>Haselhorst, Thomas</au><au>von Itzstein, Mark</au><au>Pinto, Brian Mario</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2010-10-28</date><risdate>2010</risdate><volume>53</volume><issue>20</issue><spage>7377</spage><epage>7391</epage><pages>7377-7391</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>We report here the exploitation of the 150-cavity in the active sites of group-1 neuraminidases for the design of new triazole-containing carbocycles related to oseltamivir. Inhibition studies with virus-like particles (VLPs) containing the influenza virus neuraminidase-1 (N1) activity indicate that several candidates are inhibitors, with K i values in the 10−5−10−8 M range. In contrast, a known candidate that preserves the free amino group and a new candidate containing a guanidine function are better inhibitors, with K i values of 1.5 × 10−9 and 4.6 × 10−10 M, respectively. The most active inhibitor of the N1 enzyme in the triazole series was selective for the N1 class and showed significantly less inhibition (K i = 2.6 μM vs 0.07 μM) of the free influenza virus neuraminidase-2 (N2). In addition, saturation transfer difference (STD) NMR spectroscopic studies with this compound and the VLPs show that the entire molecule forms contacts with residues in the active site. These data taken together support our proposed binding mode in which the active site and the adjoining 150-cavity are both occupied.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>20873795</pmid><doi>10.1021/jm100822f</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2010-10, Vol.53 (20), p.7377-7391
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_759874583
source MEDLINE; ACS Publications
subjects Antiviral Agents - chemical synthesis
Antiviral Agents - chemistry
Catalytic Domain
Influenza A virus - enzymology
Magnetic Resonance Spectroscopy
Models, Molecular
Neuraminidase - antagonists & inhibitors
Neuraminidase - chemistry
Oseltamivir - analogs & derivatives
Oseltamivir - chemical synthesis
Oseltamivir - chemistry
Protein Binding
Stereoisomerism
Triazoles - chemical synthesis
Triazoles - chemistry
Virion - drug effects
Virion - enzymology
title Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A02%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbocycles%20Related%20to%20Oseltamivir%20as%20Influenza%20Virus%20Group-1-Specific%20Neuraminidase%20Inhibitors.%20Binding%20to%20N1%20Enzymes%20in%20the%20Context%20of%20Virus-like%20Particles&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Mohan,%20Sankar&rft.date=2010-10-28&rft.volume=53&rft.issue=20&rft.spage=7377&rft.epage=7391&rft.pages=7377-7391&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm100822f&rft_dat=%3Cproquest_cross%3E759874583%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=759874583&rft_id=info:pmid/20873795&rfr_iscdi=true